Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-04-15

Clinical Trial Update: Lipoic Acid Supplement for Cystine Stone [Phase 2]

View source ↗

Summary

Phase 2 trial of alpha-lipoic acid for limiting cystine stone recurrence in cystinuria was completed, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Alpha Lipoic Acid (alpha-lipoic acid)

Snippet

Sponsor: Thomas Chi, MD | Conditions: Cystinuria | Phase 2 | Status: COMPLETED | Results posted: 2026-04-15